Prognostic value of 3D mean CT attenuation in the solid component of resected part-solid lung adenocarcinomas.

IF 1.9 3区 医学 Q3 RESPIRATORY SYSTEM
Journal of thoracic disease Pub Date : 2026-03-31 Epub Date: 2026-02-26 DOI:10.21037/jtd-2025-1790
Ryohei Miyazaki, Masaya Tamura, Takashi Sakai, Naoki Furukawa, Yujiro Bunno, Marino Yamamoto, Hironobu Okada
{"title":"Prognostic value of 3D mean CT attenuation in the solid component of resected part-solid lung adenocarcinomas.","authors":"Ryohei Miyazaki, Masaya Tamura, Takashi Sakai, Naoki Furukawa, Yujiro Bunno, Marino Yamamoto, Hironobu Okada","doi":"10.21037/jtd-2025-1790","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Preoperative prediction of recurrence in non-small cell lung cancer (NSCLC) remains limited using conventional imaging parameters such as tumor size, consolidation-to-tumor (C/T) ratio, and 2D mean computed tomography attenuation (mCT) value. This study aimed to evaluate the prognostic utility of the 3D-solid mCT value in patients with surgically resected NSCLC.</p><p><strong>Methods: </strong>A total of 138 patients with part-solid adenocarcinomas who underwent complete resection between 2012 and 2018 were retrospectively analyzed. Preoperative CT data were processed using a 3D workstation to measure tumor volume and calculate the 3D-solid mCT value. Recurrence-free survival (RFS) was the primary outcome. Receiver operating characteristic (ROC) analysis was used to identify optimal cut-off values. Survival was analyzed using Kaplan-Meier and Cox proportional hazards models.</p><p><strong>Results: </strong>Patients were divided into high (≥-106.0 HU) and low (<-106.0 HU) 3D-solid mCT value groups. The high value group showed significantly worse 5-year RFS (65.8% <i>vs.</i> 98.4%, P<0.001). The 3D-solid mCT value had the highest predictive accuracy for recurrence [area under the curve (AUC) =0.724] compared to the 2D-mCT value (AUC =0.643, P=0.02) and C/T ratio (AUC =0.598). Multivariate analysis identified high 3D-solid mCT value (hazard ratio: 9.22, P=0.02) and lymphatic invasion (P=0.002) as independent predictors of recurrence.</p><p><strong>Conclusions: </strong>The 3D-solid mCT value is a strong, independent predictor of postoperative recurrence in NSCLC and showed better predictive performance than conventional 2D imaging parameters in ROC analysis. Preoperative assessment of this value may help identify high-risk patients and support personalized postoperative management. However, further studies with formal model comparison are warranted to confirm its superiority.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"18 3","pages":"208"},"PeriodicalIF":1.9000,"publicationDate":"2026-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13077412/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thoracic disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jtd-2025-1790","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Preoperative prediction of recurrence in non-small cell lung cancer (NSCLC) remains limited using conventional imaging parameters such as tumor size, consolidation-to-tumor (C/T) ratio, and 2D mean computed tomography attenuation (mCT) value. This study aimed to evaluate the prognostic utility of the 3D-solid mCT value in patients with surgically resected NSCLC.

Methods: A total of 138 patients with part-solid adenocarcinomas who underwent complete resection between 2012 and 2018 were retrospectively analyzed. Preoperative CT data were processed using a 3D workstation to measure tumor volume and calculate the 3D-solid mCT value. Recurrence-free survival (RFS) was the primary outcome. Receiver operating characteristic (ROC) analysis was used to identify optimal cut-off values. Survival was analyzed using Kaplan-Meier and Cox proportional hazards models.

Results: Patients were divided into high (≥-106.0 HU) and low (<-106.0 HU) 3D-solid mCT value groups. The high value group showed significantly worse 5-year RFS (65.8% vs. 98.4%, P<0.001). The 3D-solid mCT value had the highest predictive accuracy for recurrence [area under the curve (AUC) =0.724] compared to the 2D-mCT value (AUC =0.643, P=0.02) and C/T ratio (AUC =0.598). Multivariate analysis identified high 3D-solid mCT value (hazard ratio: 9.22, P=0.02) and lymphatic invasion (P=0.002) as independent predictors of recurrence.

Conclusions: The 3D-solid mCT value is a strong, independent predictor of postoperative recurrence in NSCLC and showed better predictive performance than conventional 2D imaging parameters in ROC analysis. Preoperative assessment of this value may help identify high-risk patients and support personalized postoperative management. However, further studies with formal model comparison are warranted to confirm its superiority.

切除部分实性肺腺癌实性部分三维平均CT衰减的预后价值。
背景:术前预测非小细胞肺癌(NSCLC)复发的常规影像学参数仍然有限,如肿瘤大小、实变与肿瘤(C/T)比和二维平均计算机断层扫描衰减(mCT)值。本研究旨在评估3d -实体mCT在手术切除的非小细胞肺癌患者中的预后价值。方法:回顾性分析2012年至2018年接受全切除术的138例部分实体腺癌患者。术前CT数据采用三维工作站处理,测量肿瘤体积,计算三维实体mCT值。无复发生存期(RFS)是主要终点。采用受试者工作特征(ROC)分析确定最佳临界值。生存率分析采用Kaplan-Meier和Cox比例风险模型。结果:患者分为高(≥-106.0 HU)和低(vs. 98.4%)。结论:3d -实体mCT值是NSCLC术后复发的一个强有力的、独立的预测指标,在ROC分析中比传统的2D成像参数具有更好的预测性能。术前评估该值可以帮助识别高危患者,并支持个性化的术后管理。然而,需要进一步的研究与形式模型比较来证实其优越性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of thoracic disease
Journal of thoracic disease RESPIRATORY SYSTEM-
CiteScore
4.60
自引率
4.00%
发文量
254
期刊介绍: The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书